Drugs for Neglected Diseases initiative (DNDi)

DNDi is a non-profit medical research and development organization that focuses on developing new treatments for neglected diseases, such as leishmaniasis, Chagas disease, sleeping sickness, and pediatric HIV. Founded in 2003 by Médecins Sans Frontières (MSF) and other public partners, it operates on a collaborative, needs-driven model, acting as a 'conductor of a virtual orchestra' by partnering with academia, the pharmaceutical industry, and governments. The organization bridges R&D gaps by initiating and coordinating drug development projects from discovery through to clinical trials and regulatory approval. DNDi is known for its 'public interest R&D' model, which prioritizes patient needs over profit, ensuring that new medical innovations are affordable, available, and adapted to the communities that need them most.